CFTR and respiratory tract infectious disorder: Almost 40% had a respiratory infection by P. aeruginosa, 45.5% were taking inhaled steroids, 35.7% azithromycin, 27.3% other systemic antibiotics, and 25.2% were being treated with CFTR modulators.